Preventive Healthcare Technologies and Services Market
Preventive Healthcare Technologies and Services Market Analysis by Early Detection & Screening Technologies, by Prophylaxis Technologies, by Advanced Technologies to Reduce Errors, by Chronic Disease Management Technologies, by Region – Global Forecast 2021 to 2028
Analysis of Preventive Healthcare Technologies and Services market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Preventive Healthcare Technologies and Services Market Outlook (2021 to 2028)
The preventive healthcare technologies and services market is projected to surge ahead at an astronomical CAGR of 13% from 2021 to 2028. In 2020, revenue from preventive healthcare technologies and services was US$ 217.1 Mn, which is anticipated to reach US$ 557.5 Mn by the end of 2028.
| Report Attributes | Details |
|---|---|
| Preventive Healthcare Technologies and Services Market Size (2020) | US$ 217.1 Mn |
| Projected Year Value (2028F) | US$ 557.5 Mn |
| Global Market Growth Rate (2021 to 2028) | 13% CAGR |
| Key Companies Profiled | Dilon Technologies Inc.; Myraid Genetics Inc.; Noxx Systems Inc.; U-Systems Inc.; Viatronix Inc.; Lifecom Inc.; Scripto LLC; Omnicell Inc.; Sanofi Pasteur MSD; Merck & Co.; GlaxoSmithKline plc; Alere Healthways Inc.; Omron Healthcare Inc.; Medtronic |
The world has witnessed major increase in chronic diseases, and this has driven demand for chronic disease management and also given impetus to the demand for preventive healthcare services and technologies.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Consumption Analysis of Preventive Healthcare Technologies and Services (2017 to 2020) in Comparison to Market Forecasts (2021 to 2028)
Technological proliferation has increased in almost all industry verticals, and the healthcare industry is no exception to this trend. Digital healthcare technologies have seen a massive increase in popularity in recent years and this trend is expected to be prominent over the coming years as well.
Use of technology in the healthcare industry has enabled early detection & screening of multiple diseases which has also benefitted the patients as they are able to opt for treatments early and have a better chance of recovery.
Focus on healthcare has been bolstered across the world and this trend has increased the burden on healthcare systems, and to reduce this burden there have been efforts to promote preventive healthcare which are driving demand for preventive healthcare technologies and services.
Digital healthcare technology has enabled the use of prophylaxis technologies and electronic prescribing which are helping reduce healthcare costs while reducing the burden on healthcare systems.
High costs of deployment and maintenance are expected to hinder preventive healthcare technologies and services market growth through 2028. Nevertheless, the preventive healthcare technologies and services market is anticipated to evolve at a phenomenal CAGR of 13% from 2021 to 2028.
What Impact Does Increasing Focus on Healthcare Have on Market Growth?
“Rising Focus on Healthcare Promotes Adoption of Digital Healthcare Technology”
In the past years, an increase in the prevalence of multiple chronic and infectious diseases has been observed and this has subsequently increased the focus on healthcare by governments as well as individuals. This has led to increased investments in the development of healthcare infrastructure to deal with the increasing burden.
Digital healthcare technologies have been preferred for this as they have proven their efficacy in better chronic disease management in the time of pandemic in 2020. The pandemic saw major use of these digital healthcare technologies and has boosted the preventive healthcare technologies and services market potential for the forecast period through 2028.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Will High Cost of Preventive Healthcare Hamper Market Growth Potential?
“High Costs of Maintenance & Installation Could Constrain Market Growth to Some Extent”
Preventive healthcare technologies and services incur high costs for healthcare institutions as the equipment is costly and installation as well.
Moreover, the maintenance costs associated with these preventive healthcare technologies and services are also expected to slow down their adoption on a global scale.
Which Regions Experience High Demand for Preventive Healthcare Technologies and Services?
“North America & Europe Hold Substantial Market Share”
The North America preventive healthcare technologies and services market is anticipated to be the most lucrative one in the global industry landscape. The presence of advanced healthcare infrastructure and the presence of major market players are anticipated to be the prime drivers for preventive healthcare technologies and services demand in this region through 2028.
Rapid adoption of novel technologies is also expected to be a major influential factor in this region. This region is anticipated to hold a market share of nearly 40% in the global preventive healthcare technologies and services market landscape by the end of 2028.
The market for preventive healthcare technologies and services in Europe is also expected to hold a significant market share over the forecast period owing to the presence of developed healthcare infrastructure and increased healthcare expenditure. Germany, France, and the U.K are anticipated to be the most prominent markets for preventive healthcare technologies and services in this region.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Insights
Will Preventive Healthcare Technologies and Services Demand See a Hike in the U.S.?
“Increasing Healthcare Spending Potential to Drive Demand for Digital Healthcare Technology”
The U.S. is known for its advanced and developed healthcare infrastructure which provides a lucrative setting for the adoption of novel digital healthcare technologies.
Increasing burden on healthcare infrastructure and rising support from the government to boost awareness are expected to be major trends boosting the adoption of preventive medicine, prophylaxis technologies, electronic prescribing, and other technologies in the U.S.
Should Preventive Healthcare Technology and Service Providers Focus on China?
“Increasing Investments in Healthcare Sector Driving Demand for Early Detection & Screening”
China is one of the prime healthcare industries in the Asian region owing to its status of the most populous nation in the world. Focus on healthcare has increased substantially in past years owing to the increasing prevalence of chronic diseases in the nation.
The government is also increasing its investments in the healthcare sector to develop efficient chronic disease management systems and infrastructure.
Emergence of the COVID-19 pandemic in China has also propelled the demand for prophylaxis technologies and preventive medicines. Rising demand for early detection & screening will also promote the adoption of other technologies such as electronic prescribing and smart infusion pumps.
Category-wise Insights
Will Prophylaxis Technologies Perform Well through 2028?
“Rising Use of Vaccines Driving Demand for Prophylaxis Technologies”
Prophylactic measures have gained massive popularity in recent years and this trend is expected to be prominent over the forecast period as well. These measures enable the formulation of vaccines that facilitate the development of antibodies that help combat diseases.
Increased use of vaccines for diseases such as Ebola, Hepatitis C, COVID, and AIDS is also expected to bolster the growth of the prophylaxis technologies segment over the forecast period.
Competitive Landscape
Key preventive healthcare technology and service providers are focusing on increasing awareness regarding preventive medicine and are launching new initiatives to boost the same.
- In April 2022, the AIG Hospital based in Hyderabad, India, announced the launch of new wellness centers that are solely aimed at revolutionizing preventive healthcare in India by increasing awareness about personalized and preventive medicines.
Key Segments Covered in Preventive Healthcare Technologies and Services Industry Research
-
By Early Detection & Screening Technologies:
- Personalized Medicines
- Automated Screening
- Other Advanced Screening Tests
-
By Prophylaxis Technologies:
- Flu Vaccines
- Meningococcal Vaccines
- Combined Tetanus-Diphtheria-Pertussis Vaccines
- Human Papillomavirus Vaccines
- Other New Vaccines
-
By Advanced Technologies to Reduce Errors:
- Electronic Prescribing
- Computerized Provider Order Entry Systems
- Clinical Decision Support Systems
- Automated Prescription, Formulation, and Dispensing
- Smart Infusion Pumps
- Smart Packaging
-
By Chronic Disease Management Technologies:
- Blood Pressure Monitors
- Glucose Monitors
- Cardiac Monitors
- Asthma Monitors
-
By Region:
- North America Preventive Healthcare Technologies and Services Market
- Latin America Preventive Healthcare Technologies and Services Market
- Europe Preventive Healthcare Technologies and Services Market
- East Asia Preventive Healthcare Technologies and Services Market
- South Asia & Oceania Preventive Healthcare Technologies and Services Market
- MEA Preventive Healthcare Technologies and Services Market
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028)
- 6. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028), by Early Detection & Screening Technologies
- 6.1.1. Personalized Medicines
- 6.1.2. Automated Screening
- 6.1.3. Other Advanced Screening Tests
- 7. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028), by Prophylaxis Technologies
- 7.1.1. Flu Vaccines
- 7.1.2. Meningococcal Vaccines
- 7.1.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
- 7.1.4. Human Papillomavirus Vaccines
- 8. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028), by Advanced Technologies to Reduce Errors
- 8.1.1. Electronic Prescribing
- 8.1.2. Computerized Provider Order Entry Systems
- 8.1.3. Clinical Decision Support Systems
- 8.1.4. Automated Prescription, Formulation, and Dispensing
- 8.1.5. Smart Infusion Pumps
- 8.1.6. Smart Packaging
- 9. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028), by Chronic Disease Management Technologies
- 9.1.1. Blood Pressure Monitors
- 9.1.2. Glucose Monitors
- 9.1.3. Cardiac Monitors
- 9.1.4. Asthma Monitors
- 10. Global Market Analysis (2017 to 2020) and Forecast (2021 to 2028), by Region
- 10.1.1. North America
- 10.1.2. Europe
- 10.1.3. East Asia
- 10.1.4. South Asia
- 10.1.5. Latin America
- 10.1.6. Middle East & Africa (MEA)
- 10.1.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Dilon Technologies Inc.
- 20.2. Myraid Genetics Inc.
- 20.3. Noxx Systems Inc.
- 20.4. U-Systems Inc.
- 20.5. Viatronix Inc.
- 20.6. Lifecom Inc.
- 20.7. Scripto LLC
- 20.8. Omnicell Inc.
- 20.9. Sanofi Pasteur MSD
- 20.10. Merck & Co.
- 20.11. GlaxoSmithKline plc
- 20.12. Alere Healthways Inc.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 02: Global Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 03: Global Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 04: Global Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 05: Global Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 06: Global Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 07: Global Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 08: Global Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 09: Global Market Volume (Units), by Region, 2017to 2028
Table 10: Global Market Value (US$ Th.), by Region, 2017to 2028
Table 11: North America Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 12: North America Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 13: North America Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 14: North America Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 15: North America Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 16: North America Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 17: North America Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 18: North America Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 19: North America Market Volume (Units), by Country, 2017to 2028
Table 20: North America Market Value (US$ Th.), by Country, 2017to 2028
Table 21: Europe Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 22: Europe Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 23: Europe Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 24: Europe Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 25: Europe Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 26: Europe Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 27: Europe Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 28: Europe Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 29: Europe Market Volume (Units), by Country, 2017to 2028
Table 30: Europe Market Value (US$ Th.), by Country, 2017to 2028
Table 31: East Asia Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 32: East Asia Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 33: East Asia Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 34: East Asia Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 35: East Asia Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 36: East Asia Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 37: East Asia Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 38: East Asia Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 39: East Asia Market Volume (Units), by Country, 2017to 2028
Table 40: East Asia Market Value (US$ Th.), by Country, 2017to 2028
Table 41: South Asia Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 42: South Asia Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 43: South Asia Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 44: South Asia Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 45: South Asia Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 46: South Asia Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 47: South Asia Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 48: South Asia Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 49: South Asia Market Volume (Units), by Country, 2017to 2028
Table 50: South Asia Market Value (US$ Th.), by Country, 2017to 2028
Table 51: Latin America Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 52: Latin America Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 53: Latin America Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 54: Latin America Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 55: Latin America Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 56: Latin America Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 57: Latin America Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 58: Latin America Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 59: Latin America Market Volume (Units), by Country, 2017to 2028
Table 60: Latin America Market Value (US$ Th.), by Country, 2017to 2028
Table 61: Middle East and Africa Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 62: Middle East and Africa Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 63: Middle East and Africa Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 64: Middle East and Africa Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 65: Middle East and Africa Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 66: Middle East and Africa Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 67: Middle East and Africa Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 68: Middle East and Africa Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 69: Middle East and Africa Market Volume (Units), by Country, 2017to 2028
Table 70: Middle East and Africa Market Value (US$ Th.), by Country, 2017to 2028
Table 71: Oceania Market Volume (Units), by Early Detection & Screening Technologies, 2017to 2028
Table 72: Oceania Market Value (US$ Th.), by Early Detection & Screening Technologies, 2017to 2028
Table 73: Oceania Market Volume (Units), by Prophylaxis Technologies, 2017to 2028
Table 74: Oceania Market Value (US$ Th.), by Prophylaxis Technologies, 2017to 2028
Table 75: Oceania Market Volume (Units), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 76: Oceania Market Value (US$ Th.), by Advanced Technologies to Reduce Errors, 2017to 2028
Table 77: Oceania Market Volume (Units), by Chronic Disease Management Technologies, 2017to 2028
Table 78: Oceania Market Value (US$ Th.), by Chronic Disease Management Technologies, 2017to 2028
Table 79: Oceania Market Volume (Units), by Country, 2017to 2028
Table 80: Oceania Market Value (US$ Th.), by Country, 2017to 2028
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2017 to 2028
Fig 02: Global Absolute $ Historical Market (2017 to 2020) and Absolute $ Opportunity (2021 to 2028), US$ Th.
Fig 03: Global Absolute Historical Volume Market (2017 to 2020) and Absolute Volume Opportunity (2021 to 2028), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2021 to 2028
Fig 06: Global Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 07: Global Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 08: Global Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 09: Global Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 10: Global Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 11: Global Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 12: Global Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 13: Global Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 14: Global Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 15: Global Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 16: Global Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 17: Global Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 18: Global Market Share, by Region – 2021 to 2028
Fig 19: Global Market Y-o-Y Growth Projections, by Region – 2021 to 2028
Fig 20: Global Market Attractiveness Index, by Region – 2021 to 2028
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 24: North America Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 25: North America Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 26: North America Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 27: North America Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 28: North America Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 29: North America Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 30: North America Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 31: North America Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 32: North America Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 33: North America Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 34: North America Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 35: North America Market Share, By Country – 2021 to 2028
Fig 36: North America Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 37: North America Market Attractiveness Index, By Country – 2021 to 2028
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 41: Europe Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 42: Europe Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 43: Europe Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 44: Europe Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 45: Europe Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 46: Europe Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 47: Europe Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 48: Europe Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 49: Europe Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 50: Europe Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 51: Europe Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 52: Europe Market Share, By Country – 2021 to 2028
Fig 53: Europe Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 54: Europe Market Attractiveness Index, By Country – 2021 to 2028
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 58: East Asia Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 59: East Asia Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 60: East Asia Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 61: East Asia Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 62: East Asia Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 63: East Asia Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 64: East Asia Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 65: East Asia Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 66: East Asia Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 67: East Asia Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 68: East Asia Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 69: East Asia Market Share, By Country – 2021 to 2028
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 71: East Asia Market Attractiveness Index, By Country – 2021 to 2028
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 75: South Asia Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 76: South Asia Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 77: South Asia Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 78: South Asia Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 79: South Asia Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 80: South Asia Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 81: South Asia Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 82: South Asia Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 83: South Asia Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 84: South Asia Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 85: South Asia Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 86: South Asia Market Share, By Country – 2021 to 2028
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 88: South Asia Market Attractiveness Index, By Country – 2021 to 2028
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 92: Latin America Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 93: Latin America Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 94: Latin America Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 95: Latin America Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 96: Latin America Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 97: Latin America Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 98: Latin America Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 99: Latin America Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 100: Latin America Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 101: Latin America Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 102: Latin America Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 103: Latin America Market Share, By Country – 2021 to 2028
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 105: Latin America Market Attractiveness Index, By Country – 2021 to 2028
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 109: MEA Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 110: MEA Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 111: MEA Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 112: MEA Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 113: MEA Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 114: MEA Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 115: MEA Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 116: MEA Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 117: MEA Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 118: MEA Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 119: MEA Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 120: MEA Market Share, By Country – 2021 to 2028
Fig 121: MEA Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 122: MEA Market Attractiveness Index, By Country – 2021 to 2028
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2028
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Early Detection & Screening Technologies – 2021 to 2028
Fig 126: Oceania Market Y-o-Y Growth Projections, By Early Detection & Screening Technologies – 2021 to 2028
Fig 127: Oceania Market Attractiveness Index, By Early Detection & Screening Technologies – 2021 to 2028
Fig 128: Oceania Market Share, By Prophylaxis Technologies – 2021 to 2028
Fig 129: Oceania Market Y-o-Y Growth Projections, By Prophylaxis Technologies – 2021 to 2028
Fig 130: Oceania Market Attractiveness Index, By Prophylaxis Technologies – 2021 to 2028
Fig 131: Oceania Market Share, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 132: Oceania Market Y-o-Y Growth Projections, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 133: Oceania Market Attractiveness Index, By Advanced Technologies to Reduce Errors – 2021 to 2028
Fig 134: Oceania Market Share, By Chronic Disease Management Technologies – 2021 to 2028
Fig 135: Oceania Market Y-o-Y Growth Projections, By Chronic Disease Management Technologies – 2021 to 2028
Fig 136: Oceania Market Attractiveness Index, By Chronic Disease Management Technologies – 2021 to 2028
Fig 137: Oceania Market Share, By Country – 2021 to 2028
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country – 2021 to 2028
Fig 139: Oceania Market Attractiveness Index, By Country – 2021 to 2028
Fig 140: United States Market share by Early Detection & Screening Technologies, 2020
Fig 141: United States Market share by Prophylaxis Technologies, 2020
Fig 142: United States Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 143: United States Market Share by Chronic Disease Management Technologies, 2020
Fig 144: Canada Market share by Early Detection & Screening Technologies, 2020
Fig 145: Canada Market share by Prophylaxis Technologies, 2020
Fig 146: Canada Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 147: Canada Market Share by Chronic Disease Management Technologies, 2020
Fig 148: Germany Market share by Early Detection & Screening Technologies, 2020
Fig 149: Germany Market share by Prophylaxis Technologies, 2020
Fig 150: Germany Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 151: Germany Market Share by Chronic Disease Management Technologies, 2020
Fig 152: United Kingdom Market share by Early Detection & Screening Technologies, 2020
Fig 153: United Kingdom Market share by Prophylaxis Technologies, 2020
Fig 154: United Kingdom Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 155: United Kingdom Market Share by Chronic Disease Management Technologies, 2020
Fig 156: France Market share by Early Detection & Screening Technologies, 2020
Fig 157: France Market share by Prophylaxis Technologies, 2020
Fig 158: France Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 159: France Market Share by Chronic Disease Management Technologies, 2020
Fig 160: Russia Market share by Early Detection & Screening Technologies, 2020
Fig 161: Russia Market share by Prophylaxis Technologies, 2020
Fig 162: Russia Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 163: Russia Market Share by Chronic Disease Management Technologies, 2020
Fig 164: Spain Market share by Early Detection & Screening Technologies, 2020
Fig 165: Spain Market share by Prophylaxis Technologies, 2020
Fig 166: Spain Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 167: Spain Market Share by Chronic Disease Management Technologies, 2020
Fig 168: Italy Market share by Early Detection & Screening Technologies, 2020
Fig 169: Italy Market share by Prophylaxis Technologies, 2020
Fig 170: Italy Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 171: Italy Market Share by Chronic Disease Management Technologies, 2020
Fig 172: China Market share by Early Detection & Screening Technologies, 2020
Fig 173: China Market share by Prophylaxis Technologies, 2020
Fig 174: China Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 175: China Market Share by Chronic Disease Management Technologies, 2020
Fig 176: Japan Market share by Early Detection & Screening Technologies, 2020
Fig 177: Japan Market share by Prophylaxis Technologies, 2020
Fig 178: Japan Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 179: Japan Market Share by Chronic Disease Management Technologies, 2020
Fig 180: South Korea Market share by Early Detection & Screening Technologies, 2020
Fig 181: South Korea Market share by Prophylaxis Technologies, 2020
Fig 182: South Korea Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 183: South Korea Market Share by Chronic Disease Management Technologies, 2020
Fig 184: India Market share by Early Detection & Screening Technologies, 2020
Fig 185: India Market share by Prophylaxis Technologies, 2020
Fig 186: India Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 187: India Market Share by Chronic Disease Management Technologies, 2020
Fig 188: Singapore Market share by Early Detection & Screening Technologies, 2020
Fig 189: Singapore Market share by Prophylaxis Technologies, 2020
Fig 190: Singapore Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 191: Singapore Market Share by Chronic Disease Management Technologies, 2020
Fig 192: Indonesia Market share by Early Detection & Screening Technologies, 2020
Fig 193: Indonesia Market share by Prophylaxis Technologies, 2020
Fig 194: Indonesia Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 195: Indonesia Market Share by Chronic Disease Management Technologies, 2020
Fig 196: Thailand Market share by Early Detection & Screening Technologies, 2020
Fig 197: Thailand Market share by Prophylaxis Technologies, 2020
Fig 198: Thailand Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 199: Thailand Market Share by Chronic Disease Management Technologies, 2020
Fig 200: Brazil Market share by Early Detection & Screening Technologies, 2020
Fig 201: Brazil Market share by Prophylaxis Technologies, 2020
Fig 202: Brazil Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 203: Brazil Market Share by Chronic Disease Management Technologies, 2020
Fig 204: Mexico Market share by Early Detection & Screening Technologies, 2020
Fig 205: Mexico Market share by Prophylaxis Technologies, 2020
Fig 206: Mexico Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 207: Mexico Market Share by Chronic Disease Management Technologies, 2020
Fig 208: Turkey Market share by Early Detection & Screening Technologies, 2020
Fig 209: Turkey Market share by Prophylaxis Technologies, 2020
Fig 210: Turkey Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 211: Turkey Market Share by Chronic Disease Management Technologies, 2020
Fig 212: GCC Countries Market share by Early Detection & Screening Technologies, 2020
Fig 213: GCC Countries Market share by Prophylaxis Technologies, 2020
Fig 214: GCC Countries Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 215: GCC Countries Market Share by Chronic Disease Management Technologies, 2020
Fig 216: South Africa Market share by Early Detection & Screening Technologies, 2020
Fig 217: South Africa Market share by Prophylaxis Technologies, 2020
Fig 218: South Africa Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 219: South Africa Market Share by Chronic Disease Management Technologies, 2020
Fig 220: Australia Market share by Early Detection & Screening Technologies, 2020
Fig 221: Australia Market share by Prophylaxis Technologies, 2020
Fig 222: Australia Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 223: Australia Market Share by Chronic Disease Management Technologies, 2020
Fig 224: New Zealand Market share by Early Detection & Screening Technologies, 2020
Fig 225: New Zealand Market share by Prophylaxis Technologies, 2020
Fig 226: New Zealand Market Value (US$ Th.) and Forecast 2021 to 2028
Fig 227: New Zealand Market Share by Chronic Disease Management Technologies, 2020
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the total market worth of the preventive healthcare technologies and services industry in 2020?
The global preventive healthcare technologies and services market totalled to a valuation of US$ 217.1 Mn in 2020.
How big is the preventive healthcare technologies and services market expected to be by 2028?
By 2028, the market for preventive healthcare technologies and services is anticipated to be worth US$ 557.5 Mn.
What is the anticipated CAGR of the preventive healthcare technologies and services market in the forecast period?
The market is estimated to expand at a stellar CAGR of 13% from 2021 to 2028.
Who are the key players operating in the preventive healthcare technologies and services market?
Key market players are Dilon Technologies Inc., Myraid Genetics Inc., Noxx Systems Inc., U-Systems Inc., Viatronix Inc., Lifecom Inc., Scripto LLC, and Omnicell Inc.
What market share is expected to be held by North America?
The North America preventive healthcare technologies and services market is anticipated to account nearly 40% of the global industry share.
Preventive Healthcare Technologies and Services Market